Aromasin



Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 62.4%
Breast Cancer Female 9.4%
Hypertension 6.1%
Breast Cancer Metastatic 5.8%
Osteopenia 1.8%
Diabetes Mellitus 1.5%
Blood Cholesterol Increased 1.3%
Breast Cancer Recurrent 1.3%
Neoplasm Malignant 1.3%
Depression 1.2%
Osteoporosis 1.1%
Ill-defined Disorder 0.9%
Hypothyroidism 0.9%
Pain 0.9%
Nasopharyngitis 0.8%
Glaucoma 0.8%
Metastases To Bone 0.8%
Asthma 0.7%
Breast Disorder 0.7%
Breast Cancer Male 0.6%
Death 19.9%
Disease Progression 10.7%
Weight Increased 7.5%
Arthralgia 7.2%
Pain In Extremity 4.8%
Weight Decreased 4.2%
Alopecia 4.1%
Vaginal Haemorrhage 4.1%
Pulmonary Embolism 3.6%
Nausea 3.5%
Hepatic Function Abnormal 3.3%
Myalgia 3.3%
Pain 3.3%
Paraesthesia 3.2%
Cerebrovascular Accident 3.0%
Interstitial Lung Disease 3.0%
Dysphagia 2.9%
Insomnia 2.9%
Rash 2.9%
Gamma-glutamyltransferase Increased 2.7%
Secondary
Breast Cancer 40.6%
Breast Cancer Metastatic 14.5%
Product Used For Unknown Indication 13.5%
Hypertension 7.1%
Drug Use For Unknown Indication 5.2%
Breast Cancer Female 3.1%
Metastases To Bone 2.9%
Pain 1.8%
Blood Cholesterol Increased 1.2%
Breast Cancer Male 1.1%
Fibromyalgia 1.1%
Ventricular Tachycardia 1.1%
Cough 1.0%
Diabetes Mellitus 1.0%
Rheumatoid Arthritis 1.0%
Autonomic Nervous System Imbalance 0.9%
Dyspepsia 0.9%
Breast Cancer Recurrent 0.7%
Gastritis Prophylaxis 0.7%
Hot Flush 0.7%
Alopecia 7.5%
Osteoporosis 7.5%
Malignant Neoplasm Progression 6.8%
Neoplasm Progression 6.8%
Arthralgia 6.0%
Pain In Extremity 6.0%
Disease Progression 5.3%
Weight Decreased 5.3%
Weight Increased 5.3%
Pain 4.5%
Syncope 4.5%
Thrombocytopenia 4.5%
Atrial Fibrillation 3.8%
Febrile Neutropenia 3.8%
Myocardial Infarction 3.8%
Neuropathy Peripheral 3.8%
Osteonecrosis 3.8%
Pulmonary Embolism 3.8%
Tongue Neoplasm Malignant Stage Unspecified 3.8%
Vomiting 3.8%
Concomitant
Breast Cancer 30.9%
Metastases To Bone 17.3%
Breast Cancer Metastatic 14.9%
Osteoporosis 3.6%
Drug Use For Unknown Indication 3.5%
Pain 3.4%
Hypertension 3.2%
Depression 3.1%
Product Used For Unknown Indication 3.1%
Anxiety 2.8%
Breast Cancer Recurrent 1.8%
Hormone Replacement Therapy 1.6%
Premedication 1.6%
Insomnia 1.5%
Neoplasm Malignant 1.5%
Multiple Myeloma 1.3%
Breakthrough Pain 1.3%
Prophylaxis 1.2%
Breast Cancer Female 1.2%
Metastases To Spine 1.2%
Weight Decreased 21.3%
Vomiting 9.3%
Tooth Extraction 8.2%
Osteonecrosis 7.9%
Wound Drainage 5.2%
Toothache 4.5%
Osteonecrosis Of Jaw 4.4%
Viral Infection 4.2%
Wound Infection Staphylococcal 4.2%
Weight Increased 3.8%
Urinary Tract Infection 3.5%
Pyrexia 3.0%
Walking Aid User 3.0%
Swelling 2.8%
Wheezing 2.8%
Wound Dehiscence 2.6%
Breast Cancer 2.4%
Diarrhoea 2.3%
Tumour Marker Increased 2.3%
Vision Blurred 2.3%
Interacting
Breast Cancer 64.9%
Hypertension 7.8%
Breast Cancer Metastatic 3.9%
Metastasis 3.9%
Autoimmune Thyroiditis 2.6%
Hyperuricaemia 2.6%
Hypothyroidism 2.6%
Anxiety 1.3%
Blood Cholesterol Increased 1.3%
Deep Vein Thrombosis 1.3%
Menopause 1.3%
Neoplasm 1.3%
Neoplasm Malignant 1.3%
Neoplasm Prophylaxis 1.3%
Supplementation Therapy 1.3%
Upper Respiratory Tract Infection 1.3%
Weight Decreased 33.3%
Hepatitis Toxic 20.0%
Gastric Disorder 6.7%
Hepatic Enzyme Increased 6.7%
International Normalised Ratio Increased 6.7%
Liver Function Test Abnormal 6.7%
Osteonecrosis 6.7%
Spinal Pain 6.7%
Urinary Incontinence 6.7%